🇺🇸 LABA in United States

23 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Death — 5 reports (21.74%)
  2. Chronic Obstructive Pulmonary Disease — 4 reports (17.39%)
  3. Condition Aggravated — 4 reports (17.39%)
  4. Drug Ineffective — 3 reports (13.04%)
  5. Asthma — 2 reports (8.7%)
  6. Acute Myocardial Infarction — 1 report (4.35%)
  7. Adverse Drug Reaction — 1 report (4.35%)
  8. Cyanosis Central — 1 report (4.35%)
  9. Decreased Appetite — 1 report (4.35%)
  10. Depression Suicidal — 1 report (4.35%)

Source database →

LABA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is LABA approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for LABA in United States?

Novartis Pharmaceuticals is the originator. The local marketing authorisation holder may differ — check the official source linked above.